Quantcast Two Bevacizumab-Based Combination Regimens Equally Effective In Patients With Metastatic - Congoo
 
 
WORLD Log In
Two Bevacizumab-Based Combination Regimens Equally Effective in Patients With Metastatic
Have an interest in this Story?
Sign Up for Real-Time email updates
Doctors Guide  | July 03, 2009

-- Combining bevacizumab (BEV) with capecitabine plus irinotecan (XELIRI) is an effective alternative to BEV plus 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in patients with metastatic colorectal cancer (mCRC), researchers reported here at the 11th World Gastrointestinal Cancer Cong...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Matthew Clark Matthew Clark
Mentor
Entrepreneur
Martin P. Lee Martin P. Lee
Associate Lecturer
Knowledge Management

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.